Tacalyx researches and develops therapeutics directed against TACAs (tumour-associated carbohydrate antigens). These strongly tumor-specific structures are synthesized by cancer cells and contribute significantly to its virulence and metastasis.
The recent synthesis of these complex structures - TACAs (tumor-associated carbohydrate antigens) - allows the production of specific antibodies that can be used for the treatment of currently unsatisfactorily treatable cancers.
This information is exclusive for Startbase Community members. You can signup for free in less than 1 minute!
This feature is exclusive for Startbase Community members. You can signup for free in less than 1 minute!